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OUTLINE OF PRESENTATION
§ Pathophysiology of CAH
§ Medical Aspects of Management
§ Surgical Aspects
§ Outcomes
§ Key Role of Endocrine Specialist Nurse
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PATHOPHYSIOLOGY OF CAH
Engels, 2019 (adapted)
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CORTISOL
JUST REPLACE THE CORTISOL
§ Cortisol has a diurnal rhythm
§ Peak 0700 – 0900; trough 2200 - 0300
§ Hydrocortisone short half-life: 60 min
§ Require tds dosing; provides < 24hr cover
Not so simple
NEWER TREATMENTS FOR CAH
El-Maouche, 2017
USE OF MODIFIED RELEASE 
HYDROCORTISONE
§ Plenadren
immediate and delayed-release HC 
combined once daily, on wakening
§ Chronocort
modified-release formulation twice daily, 
at night and on wakening
REPLICATING THE CORTISOL 
DIURNAL RHYTHM
Porter et al,  2017
Normal cortisol profile
Chronocort in CAH
SURGICAL ISSUES
↑
Surgery ?
↑
Surgery ?
When ?
OUTCOMES IN CAH
§ Growth and puberty
considerable improvements
final height within population standards
§ Reproduction
high success rate in females, BUT low maternalism
non-compliance in males; testicular adrenal rests
§ Adult morbidity
cardiovascular
bone health
decreased QoL
increased mortality
CONGENITAL ADRENAL 
HYPERPLASIA
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• Fetal
• neonatal
newborn screening
clinical diagnosis
early treatment
• childhood/adolescence
growth
puberty
• adulthood
metabolic aspects
fertility
pregnancy
genetic counselling
Obstetrician
Endocrinologist
Urologist
Gynaecologist
Psychologist
Geneticist
Specialist Nurse
Ethicist
Support groups
Management
Nursing issues..
§ 3.1 pay special attention to 
promoting wellbeing, 
preventing ill health and 
meeting the changing health 
and care needs of people 
during all life stages
§ 3.4 act as an advocate for the 
vulnerable
§ 6.1 make sure that any 
information or advice given is 
evidence-based, including 
information relating to using 
any health and care products 
or services
Literature search: CAH 2019
Cardiovascular health
- Children with CAH now at risk of cardiovascular risk            
factors
- Treatment regimens?
- PENS role
Treatment regimens
§ Alkindi Hydrocortisone granules well tolerated in 
children less than 6 years of age
Neumann et al Clin Endocrinol 2018; 88: 21 – 9
Alkindi granules 
Journal of the Endocrine Society, May 2019, Vol 3, Iss. 5
Surgery in girls
Curr Opin Endocrinol Diabetes Obes 2019 Feb;26(1):49-53
- When the child can make the decision or earlier?
- Patient advocacy groups
- Reduce stigma
@dsdfamilies
Nurses’ key roles
§ Important to be aware of current research
§ Evidence based practice
§ Work in partnership with multi-disciplinary team
NEJM Aug 29 2019
